FDA Clearance Tracker · K222933
MYAH
Last checked: Nov 19, 2026Latest source record: Jun 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 29, 2023
Substantially Equivalent
Time to decision
276 days
Received Sep 26, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K222933
- Device name
- MYAH
- Applicant
- Visia Imaging S.R.L.
- Applicant location
- San Giovanni Valdarno, IT
- Received
- Sep 26, 2022
- Decided
- Jun 29, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Device, Analysis, Anterior Segment (MXK)
- Device class
- Class II
- Regulation
- 21 CFR 886.1850
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MXK. The earliest in FDA's data is K984443, decided Mar 5, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K222933
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Visia Imaging S.R.L.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MYAH510(k)
K211868 · Decided Mar 1, 2022 · 258 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
- ALADDIN HW3.0510(k)
K160327 · Decided Oct 5, 2016 · 243 days after receipt
Device type: Biomicroscope, Slit-Lamp, Ac-Powered (HJO) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.